Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical diltiazem plus metronidazole versus diltiazem alone for acute anal fissure
IRCT20220206053958N6Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in anal fissure comparing Topical diltiazem alone with Topical diltiazem plus topical metronidazole (2 arms). Primary endpoint: Pain intensity during defecation. Started Jun 2026; status: completed.
02
Drugs
diltiazemmetronidazole
03
Conditions
anal fissure
Beyond the preview
Go deeper on IRCT20220206053958N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220206053958N6.